George Kemble
Fortune : 616 637 $ au 31/10/2026
Fortune : 616 637 $ au 31/10/2026
George W.
Kemble is Executive Chairman at Sagimet Biosciences, Inc. since 2022.
Formerly, Dr. Kemble was Senior Vice President-Research & Development at MedImmune LLC from 2001 to 2011.
Other former roles include Director at LigoCyte Pharmaceuticals, Inc. and Staff Scientist at MedImmune Vaccines, Inc. Education includes a doctorate from Stanford University and an undergraduate degree from Santa Clara University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/08/2026 | 62 161 ( 0,09 % ) | 616 637 $ | 31/10/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SAGIMET BIOSCIENCES INC. | Président | 24/10/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Directeur Technique/Scientifique/R&D | 01/01/2011 |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology Develops, manufactures and markets live vaccines | Corporate Officer/Principal | - |
LigoCyte Pharmaceuticals, Inc.
LigoCyte Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Developed vaccines and monoclonal antibody therapeutics | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology Develops, manufactures and markets live vaccines | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Santa Clara University
Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LigoCyte Pharmaceuticals, Inc.
LigoCyte Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Developed vaccines and monoclonal antibody therapeutics | Health Technology |
Sagimet Biosciences, Inc.
Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national